GLP-1 Agonists: Diabetes Drugs and Weight Loss

by | Oct 27, 2024 | Uncategorized | 0 comments

By Obesity

GLP-1 (Glucagon-Like Peptide-1) agonists are a category of medications initially intended for the treatment of type 2 diabetes. Nevertheless, they are getting a massive spotlight for their efficacy in weight loss. An introduction to these drugs and their dual benefits are given here:

 

How GLP-1 Agonists Work

 

    • Mimic a natural hormone called GLP-1

 

    • Slow down digestion and increase feelings of fullness

 

    • Regulate blood sugar levels by stimulating insulin production

 

    • Reduce the appetite and intake of food

 

Benefits for Diabetes Management

 

    • Regulate glucose

 

    • Eliminate high-infection risks in diabetic patients

 

    • Are presumed to avert beta cells from getting damaged and to keep them high in the pancreas

 

Weight Loss Effects

 

    • Substantial weight loss in people with both diabetes and those without diabetes

 

    • Weight loss differing from 5% to 15% of the body weight in different drugs and dosages

 

    • Continous weight loss after the initial stage is maintained

 

Common GLP-1 Agonist Medications

 

    • Semaglutide (Ozempic, Wegovy)

 

    • Liraglutide (Victoza, Saxenda)

 

    • Dulaglutide (Trulicity)

 

    • Exenatide (Byetta, Bydureon)

 

The medication results have shown some improvements in both diabetic individuals and non-diabetic people in dealing with both diabetes and obesity as interconnected health issues. However, it is essential to mention that these drugs must be used by the doctor’s order and should be accompanied by lifestyle changes for the best effects.

Explore More on GLP-1 and Weight Management

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *